Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01294150 · ClinicalTrials.gov registry record · NA
The Safety and Effectiveness of UroLift: LIFT Pivotal Study
A NA study of Benign Prostatic Hyperplasia, sponsored by NeoTract.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
- 19
- Study locations
NCT01294150 is a NA study of Benign Prostatic Hyperplasia that has completed, run by NeoTract. The registered enrollment target is 206 participants, below the 545-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (62% lower). The trial reports 19 study locations across 15 states.
The verdict
NCT01294150, a NA study of Benign Prostatic Hyperplasia, has completed, sponsored by NeoTract.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
- 19
- Study locations
Study Summary
The purpose of the study is to evaluate the safety and effectiveness of the UroLift(R) System when used in subjects with symptomatic benign hyperplasia (BPH). Primary effectiveness will be achieved by looking at the improvement of International Prostate Symptom Score (IPSS) and safety will be reviewed based on pertinent adverse events.
Conditions Studied
Interventions
- DEVICE UroLift System
- OTHER Cystoscopy
- DEVICE Crossover
Study Locations (19)
California
- Genesis Research LLC - San Diego
- Shahram S. Gholami MD - A Professional Corp. - San Jose
Florida
- Advanced Urology Institute - Daytona Beach
- Pinellas Urology - St. Petersburg
Texas
- UT Southwestern Medical Center - Dallas
- Scott and White Healthcare - Temple
Ontario
- Oakville Trafalgar Memorial Hospital - Oakville
- Cam Am HIFU - Toronto
Colorado
- Urology Associates of Denver - Englewood
Illinois
- Northwestern University - Chicago
Maryland
- Chesapeake Urology - Baltimore
Nevada
- Sheldon J. Freedman, M.D., Ltd. - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2011-02 |
| Est. Completion | 2017-07-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01294150
The ClinicalTrials.gov registry entry for NCT01294150 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 545-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (62% lower). The listed sponsor is NeoTract, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 3 interventions - of which UroLift System is the first listed.
NCT01294150 reports 19 study locations spanning 15 distinct geographic areas - top geographies include California, Florida, Texas.
Frequently Asked Questions
What is clinical trial NCT01294150 about?
NCT01294150 is a clinical study titled "The Safety and Effectiveness of UroLift: LIFT Pivotal Study". The purpose of the study is to evaluate the safety and effectiveness of the UroLift(R) System when used in subjects with symptomatic benign hyperplasia (BPH). Primary effectiveness will be achieved by looking at the improvement of International Prostate Symptom Score (IPSS) and safety will be review...
What is the current status of trial NCT01294150?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2011-02. Estimated completion is 2017-07-05.
What conditions does trial NCT01294150 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia.
What interventions are being tested in trial NCT01294150?
The interventions under investigation include: UroLift System (DEVICE), Cystoscopy (OTHER), Crossover (DEVICE).
Who is sponsoring clinical trial NCT01294150?
This trial is sponsored by NeoTract, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01294150 being conducted?
This trial has 19 study locations across California, Colorado, Florida, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Benign Prostatic Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ambulatory Long Length URodynamics Evaluation
RECRUITING · NA
-
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
RECRUITING · NA
-
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
RECRUITING · NA
-
PRescription Exercise for Older Men With Urinary Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.